You are here

  • Home
  • Archive
  • Volume 68, Issue 6
  • Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

Article info

Article menu
Download PDFPDF
Paper
Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

Authors

  1. Dr A Richardson, Ipsen Limited, 1 Bath Road, Maidenhead, Berkshire SL6 4UH, UKalan.richardson{at}ipsen.co.uk
View Full Text

Citation

Hyman N, Barnes M, Bhakta B, et al
Botulinum toxin (Dysport®) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study
Journal of Neurology, Neurosurgery & Psychiatry 2000;68:707-712.

Publication history

  • Received March 19, 1999
  • Revised November 3, 1999
  • Accepted December 3, 1999
  • First published June 1, 2000.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Journal of Neurology, Neurosurgery, and Psychiatry